23ME-00610, a genetically informed, first-in-class antibody targeting CD200R1 to enhance antitumor T cell function.
Fenaux J, Fang X, Huang YM, Melero C, Bonnans C, Lowe EL, Palumbo T, Lay C, Yi Z, Zhou A, Poggio M, Chung WJ, Majeed SR, Glatt D, Chen A, Schmidt M, Lee CC.
Fenaux J, et al. Among authors: majeed sr.
Oncoimmunology. 2023 Jun 5;12(1):2217737. doi: 10.1080/2162402X.2023.2217737. eCollection 2023.
Oncoimmunology. 2023.
PMID: 37288324
Free PMC article.